Clinical trial
Study of the Safety, Tolerability and Immune Response of TBE Vaccines…
NCT00311441 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00311441 |
|---|---|
| Title | Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children |
| Official title | A Phase IV, Randomized, Controlled, Single-Blind, Multi-Center Study in Children to Evaluate the Safety, Tolerability and Immunogenicity of Two TBE Vaccines Administered According to Two Different Schedules. |
| Lead sponsor | Novartis, Industry |
| Collaborators | Novartis Vaccines Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Encephalitis, Tick-Borne |
| Intervention type | Biological |
| Interventions | Tick-Borne Encephalitis vaccine |
| Enrollment | 300 |
| Start date | Mar 1, 2005 |
| First posted | Apr 6, 2006 |
| Last update posted | Mar 17, 2008 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: